CompoAtlas

Sementis Astaxanthine

Natural health product licensed in Canada

Other names
Sementis
Licence holder
Nutra Forme Inc.
NPN or DIN-HM
80093742
Status
Active licence
Licence date
6 August 2019
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Stéarate de magnésium, Gélatine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule1 day

Uses authorised in Canada

Source d'acide aminé essentiel/Un acide aminé essentiel jouant un rôle dans la synthèse des protéines musculaires. Améliore la récupération après l'exercice. Aide à la production d'énergie. Aide à maintenir un bon fonctionnement des muscles et une bonne formation de tissus. Aide au maintien/soutien des fonctions immunitaires. Aide au métabolisme de l'énergie dans le corps. Aide au métabolisme de l'énergie et à la formation des tissus. Antioxydant pour le maintient d'une bonne santé. Source d'acide aminé essentiel/Un acide aminé essentiel jouant un rôle dans la synthèse des protéines. Un antioxydant pour une bonne santé.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80093742

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line